The pharmacology of olivopontocerebellar atrophy.
D000328:Adult; D000547:Amantadine / Q000627:therapeutic use; D001284:Atrophy; D001418:Baclofen / Q000627:therapeutic use; D001927:Brain Diseases / Q000188:drug therapy; D002230:Carbidopa / Q000627:therapeutic use; D002524:Cerebellar Ataxia / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009847:Olivary Nucleus; D011149:Pons; D011433:Propranolol / Q000627:therapeutic use; D013577:Syndrome
D007980:Levodopa; D011433:Propranolol; D000547:Amantadine; D001418:Baclofen; D002230:Carbidopa